791-Targeting uPAR-Positive Tumor with CAR T Cell Therapy

This research identifies the urokinase plasminogen activator receptor (uPAR) as a vital target for CAR T cell therapy in solid tumors. While traditional treatments struggle with the fibrotic and immunosuppressive environment of tumors, uPAR CAR T cells effectively eliminate both malignant cells and the supportive stromal niche. These engineered cells show remarkable success in clearing primary and...去小宇宙查看完整单集简介
前往小宇宙评论区与主播互动